Search Results for keywords:"poppy seeds"

The Food and Drug Administration (FDA) is asking for industry input about the growth, harvesting, processing, and distribution of poppy seeds, specifically focusing on practices that minimize their opiate alkaloid content. This request for information is due to reports of health issues linked to poppy seed products, including cases where homemade "poppy seed tea" has been connected to serious harm and deaths. The FDA seeks to understand current practices and consider possible future actions to ensure that poppy seed products are safe for consumption. Public comments on this matter are invited until April 15, 2025, through the Federal eRulemaking Portal or via written submissions.

The Food and Drug Administration (FDA) is extending the comment period for gathering information on industry practices related to poppy seeds. This includes cultivation, processing, and methods to reduce opiate alkaloid levels in poppy seeds. Due to requests for more time, the FDA is allowing an additional 60 days for comments, with submissions acceptable until June 16, 2025. This information will help the FDA decide if any actions are needed to ensure that poppy seed products are safe for consumption.